India's drug regulator has flagged a batch of the Abhayrab rabies vaccine as substandard after it failed a potency test, raising concerns about its authenticity and potential spuriousness.

IN · 2026-09-05

1. Step 1 · The triggerIndia's drug regulator flags a batch of Abhayrab rabies vaccine as substandard after potency test failure, triggering regulatory scrutiny and possible recall.
2. Step 2 · Knock-onWithheld This step of the chain is withheld. The reason is set out in the notice above — a deliberate omission, not missing data.
3. Step 3 · Knock-onCompeting vaccine manufacturers like Bharat Biotech and Serum Institute of India capture displaced demand as buyers seek alternative suppliers.
4. Step 4 · Reaches youSMEs in the pharma supply chain face procurement delays, tighter quality checks, and must adapt operations to maintain compliance and customer trust.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: Economic Times Top Stories

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.